COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS

Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.

Saved in:
Bibliographic Details
Main Authors Pagès Santacana, Lluís Miquel, Gouliaev, Alex Haahr, Erra Solà, Montserrat, Taboada Martínez, Lorena, Taltavull Moll, Joan, Nielsen, Søren Jensby, Caturla Javaloyes, Juan Francisco, Schrøder Glad, Sanne, Sarvary, Ian, Stasi, Luigi Piero, Franch, Thomas
Format Patent
LanguageEnglish
Published 24.06.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
AbstractList Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
Author Franch, Thomas
Nielsen, Søren Jensby
Sarvary, Ian
Taltavull Moll, Joan
Pagès Santacana, Lluís Miquel
Gouliaev, Alex Haahr
Taboada Martínez, Lorena
Schrøder Glad, Sanne
Stasi, Luigi Piero
Erra Solà, Montserrat
Caturla Javaloyes, Juan Francisco
Author_xml – fullname: Pagès Santacana, Lluís Miquel
– fullname: Gouliaev, Alex Haahr
– fullname: Erra Solà, Montserrat
– fullname: Taboada Martínez, Lorena
– fullname: Taltavull Moll, Joan
– fullname: Nielsen, Søren Jensby
– fullname: Caturla Javaloyes, Juan Francisco
– fullname: Schrøder Glad, Sanne
– fullname: Sarvary, Ian
– fullname: Stasi, Luigi Piero
– fullname: Franch, Thomas
BookMark eNrjYmDJy89L5WTQcvb3DfAP9XMJVnB0DvEMc1UI8Q93DAJy_UKdfVwdgxSCXJ1dA0L8g4J5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8aLCRgZGhoYWFhYG5o6ExcaoA-DMnpg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2021188807A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2021188807A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:02:19 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2021188807A13
Notes Application Number: US202017126182
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210624&DB=EPODOC&CC=US&NR=2021188807A1
ParticipantIDs epo_espacenet_US2021188807A1
PublicationCentury 2000
PublicationDate 20210624
PublicationDateYYYYMMDD 2021-06-24
PublicationDate_xml – month: 06
  year: 2021
  text: 20210624
  day: 24
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies NUEVOLUTION A/S
RelatedCompanies_xml – name: NUEVOLUTION A/S
Score 3.333912
Snippet Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210624&DB=EPODOC&locale=&CC=US&NR=2021188807A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTsXplILSB6G4tWnXPRTp0pQhri29zL2N9AaCzOEq_n1PwqZ72luSA7nBl5Mv5xKAB7tvcM6rUqsHdqmRWth3C9PSypxUdZHXZS0z3kwDa5KRl7k5b8HHNhZG5gn9kckREVEF4r2R5_Xq_xHLk76V66f8HZs-n_3U8dQNO0b-YulE9cYOi0IvpCqlTpaoQSxlA2R7_aGLXOkAL9JDgQc2G4u4lNWuUvFP4TDC_pbNGbSqZQeO6fbvtQ4cTTcmbyxu0Lc-h0caTqMwC7xEEb4fM6ak4ZsbYzXI6CtzYyVmlEVpGCcXcO-zlE40HHTxt8ZFluzO0LiENrL_6gqU3CiF9Uvno9ImuHMjg3BOeF2ZNscTwupCb19P1_vFN3AiqsL3SSc9aDdf39Utatkmv5Ob8wu7h3y7
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXp1ILSB6G4tVntHop0acbU9YN-zL2NdG1BkDlcxX_fS9h0T3tLcnD5gLvLL_cRgDurY3DOi1wru1aukVL4d-c9U8szUpTzrMxLWfHG881RSl6mvWkNPja5MLJO6I8sjogSNUd5r6S-Xv4_YrkytnL1kL3j0OfTMLFddY2OEb-YOlHdgc3CwA2oSqmdxqofSVoX0V7n0UGstIeXbEv8d8AmA5GXstw2KsMj2A-R36I6hlqxaEKDbv5ea8KBt3Z5Y3MtfasTuKeBFwap78aKiP2YMCUJ3pwIu35Kx8yJlIhRFiZBFJ_C7ZAldKThpLO_Pc7SeHuFxhnUEf0X56BkRi68Xzrv5xbBk-sbhHPCy6JncdQQZgvauzhd7CbfQGOUeOPZ-Nl_vYRDQRJxUDppQ736-i6u0OJW2bU8qF-8nX-r
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+ACTIVE+TOWARDS+NUCLEAR+RECEPTORS&rft.inventor=Pag%C3%A8s+Santacana%2C+Llu%C3%ADs+Miquel&rft.inventor=Gouliaev%2C+Alex+Haahr&rft.inventor=Erra+Sol%C3%A0%2C+Montserrat&rft.inventor=Taboada+Mart%C3%ADnez%2C+Lorena&rft.inventor=Taltavull+Moll%2C+Joan&rft.inventor=Nielsen%2C+S%C3%B8ren+Jensby&rft.inventor=Caturla+Javaloyes%2C+Juan+Francisco&rft.inventor=Schr%C3%B8der+Glad%2C+Sanne&rft.inventor=Sarvary%2C+Ian&rft.inventor=Stasi%2C+Luigi+Piero&rft.inventor=Franch%2C+Thomas&rft.date=2021-06-24&rft.externalDBID=A1&rft.externalDocID=US2021188807A1